Urology
Volume 76, Issue 3 , Pages 620-623 , September 2010

Active Surveillance for Larger (cT1bN0M0 and cT2N0M0) Renal Cortical Neoplasms

Received 26 February 2010 ,Revised 10 April 2010

References 

  1. Lane BR, Novick AC. Nephron-sparing surgery. BJU Int. 2007;99:1245–1250
  2. Patard JJ. Incidental renal tumors. Curr Opin Urol. 2009;19:454–458
  3. Desai MM, Aron M, Gill IS. Laparoscopic partial nephrectomy versus laparoscopic cryoablation for the small renal tumor. Urology. 2005;66:23–28
  4. Crispen PL, Viterbo R, Fox EB, et al. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008;112:1051–1057
  5. Abou Youssif T, Kassouf W, Steinberg J, et al. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer. 2007;110:1010–1014
  6. Jewett MA, Zuniga A. Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am. 2008;35:627–634
  7. Crispen PL, Wong YN, Greenberg RE, et al. Predicting growth of solid renal masses under active surveillance. Urol Oncol. 2008;26:555–559
  8. Crispen PL, Viterbo R, Boorjian SA, et al. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer. 2009;115:2844–2852
  9. Kunkle DA, Crispen PL, Chen DY, et al. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849–853
  10. Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–2220
  11. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  12. Fujimoto N, Sugita A, Terasawa Y, et al. Observations on the growth rate of renal cell carcinoma. Int J Urol. 1995;2:71–76
  13. Volpe A, Panzarella T, Rendon RA, et al. The natural history of incidentally detected small renal masses. Cancer. 2004;100:738–745
  14. Sowery RD, Siemens DR. Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol. 2004;11:2407–2410
  15. Kato M, Suzuki T, Suzuki Y, et al. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol. 2004;172:863–866
  16. Wehle MJ, Thiel DD, Petrou SP, et al. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology. 2004;64:49–52
  17. Rosales JC, Haramis G, Moreno J, et al. Active surveillance of renal cortical neoplasms. J Urol. Epub 2010 Mar 16.
  18. Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–431
  19. Bosniak MA, Birnbaum BA, Krinsky GA, et al. Small renal parenchymal neoplasms: further observations on growth. Radiology. 1995;197:589–597
  20. Kassouf W, Aprikian AG, Laplante M, et al. Natural history of renal masses followed expectantly. J Urol. 2007;171:111–113
  21. Lamb GW, Bromwich EJ, Vasey P, et al. Management of renal masses in patients medically unstable for nephrectomy- natural history, complications, and outcomes. Urology. 2004;64:909–913
  22. Kouba E, Smith A, McRackan D, et al. Watchful waiting for solid renal masses: insight into the the natural history and results of delayed intervention. J Urol. 2007;1777:466–470
  23. Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J Urol. 2008;180:505–508

PII: S0090-4295(10)00580-7

doi: 10.1016/j.urology.2010.04.021

Urology
Volume 76, Issue 3 , Pages 620-623 , September 2010

Article Tools